Alamar Biosciences Surges on Alzheimer's Conference News
Alamar Biosciences (ALMR) surged +7.3% to close at $28.42, a new 52-week high, after announcing its NULISA platform will be featured in over 140 presentations at the upcoming Alzheimer’s Association International Conference (AAIC). The stock outperformed both broader market indices and key industry peers like Thermo Fisher Scientific (TMO) and Illumina (ILMN), which saw minimal or negative gains.
Topics: Alzheimer's research biotech stock movement NULISA platform